Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-3654: Hsa-mir-3654 is a downregulated microRNA that has been identified in various studies [PMC8034913] [PMC6486473] [PMC4121995] [PMC8799182] [PMC9851309]. In a study on SW480/STAT3-siRNA cells, hsa-mir-3654 was one of the miRNAs that showed elevated expression levels compared to control cells [PMC4121995]. Another study found a statistically significant correlation between hsa-mir-3654 and patients' overall survival (OS) in cancer patients [PMC8799182]. Hsa-mir-3654 was also identified as one of the important cores of the ceRNET network in cancer cells [PMC8799182]. In addition, it was found to be expressed only in the Combo-Seq group and not in the small RNA group [PMC9851309]. Target prediction analysis revealed potential target genes for hsa-mir-3654, although no associated diseases were predicted for this microRNA [PMC6995532]. Furthermore, hsa-mir-3654 showed higher expression levels in LNCaP cells compared to normal and androgen-insensitive prostate cancer cell lines (PNT1A, PC-3) [PMC6780218]. Overall, hsa-mir-3654 is a downregulated microRNA that has been implicated in various biological processes and diseases [PMC8034913].
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset